Emergency endovascular stent grafting for thoracic aortic pathology

• Published in: Vascular Vol. 15; no. 1; p. 12
• Main Authors: Bos, Wendy T G J, Verhoeven, Eric L G, Zeebregts, Clark J A M, Tielliu, Ignace F J, Prins, Ted R, Oranen, Bjorn I, van den Dungen, Jan J A M
• Format: Journal Article
• Language: English
• Published: England 01.01.2007
• Subjects: Acute Disease; Adult; Aneurysm, Dissecting - surgery; Aneurysm, False - surgery; Angioplasty - instrumentation; Angioplasty - methods; Aorta, Thoracic - surgery; Aortic Aneurysm, Thoracic - mortality; Aortic Aneurysm, Thoracic - surgery; Aortic Diseases - mortality; Aortic Diseases - surgery; Aortic Rupture - mortality; Aortic Rupture - surgery; Atherosclerosis - surgery; Cohort Studies; Emergencies; Female; Fistula - surgery; Hematoma - mortality; Hematoma - surgery; Humans; Male; Middle Aged; Postoperative Complications; Reoperation; Stents; Treatment Outcome
• ISSN: 1708-5381
• DOI: 10.2310/6670.2007.00002

Our aim was to report single-center results of emergency endovascular treatment for thoracic aortic disease. From March 1998 to January 2006, 30 acute thoracic EVAR procedures were carried out in 29 patients. One patient received two procedures in different settings. Four patients died before treatment could be initiated. The pathology of aortic lesions included atherosclerotic aneurysm (n = 13), pseudoaneurysm (n = 6), aortic rupture (n = 5), type B dissection (n = 5), aortobronchial or aortoesophageal fistula (n = 4), and intramural hematoma (n = 1). The surgical mortality rate was 21%. Three patients died as a result of technical complications, and three patients died after technically successful procedures. The mean follow-up was 31 +/- 23 months. The late mortality rate was 40% (8 of 20). Four patients died of causes unrelated to the procedure; two patients died at home without autopsy. Two patients died as a consequence of graft infections. Three late nonfatal complications occurred. Two of these resulted in additional treatment: one patient developed a mycotic aneurysm that was treated with additional stent grafting, and one patient developed a type 3 endoleak after 6 years of follow-up and was successfully treated with a bridging stent graft. Endovascular treatment for acute thoracic disease is feasible and associated with a reasonable outcome. In selected cases, it may be considered as a first option.